| Patent application number | Description | Published |
|---|
| 20080262064 | Novel Compounds For The Treatment Of GI Disorders 682 - The present invention relates to novel imidazole compounds having a positive allosteric GABA | 10-23-2008 |
| 20080269216 | Imidazole Variants as Modulators of Gaba Receptor For the Treatment of Gi Disorders - The present invention relates to novel compounds having a positive allosteric GÀBAB receptor (GDR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a GABAB agonist, for the inhibition of transient lower esophageal sphincter relaxations, for the treatment of gastroesophageal reflux disease, as well as for the treatment of functional gastrointestinal disorders and irritable bowel syndrome (IBS). A compound of the general formula I | 10-30-2008 |
| 20080312291 | Heterocyclic Gaba-b Modulators - The present invention relates to novel thiazole and oxazole derivatives having a positive allosteric GABA | 12-18-2008 |
| 20080312305 | Imidazoles as Gaba- B Receptor Modulators - The present invention relates to novel imidazole derivatives having a positive allosteric GABA | 12-18-2008 |
| 20090005428 | Imidazole Derivatives for the Treatment of Gastrointestinal Disorders - The present invention relates to novel compounds having a positive allosteric GABA | 01-01-2009 |
| 20090062365 | Pyrazoles for the Treatment of GERD and IBS - The present invention relates to novel pyrazole derivatives having a positive allosteric GABAB receptor (GBR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a GABAB agonist, for the inhibition of transient lower esophageal sphincter relaxations, for the treatment of gastroesophageal reflux disease, as well as for the treatment of functional gastrointestinal disorders and irritable bowel syndrome (IBS). The compounds are represented by the general formula (I) wherein R | 03-05-2009 |
| 20090149474 | GABA-B RECEPTOR MODULATORS - The present invention relates to novel imidazole derivatives having a positive allosteric GABA | 06-11-2009 |
